ML22220A119
| ML22220A119 | |
| Person / Time | |
|---|---|
| Issue date: | 08/17/2022 |
| From: | Cindy Bladey NRC/NMSS/DREFS/RASB |
| To: | |
| Noto P | |
| References | |
| Download: ML22220A119 (20) | |
Text
Cost-Benefit Guidance Update Public Meeting August 17, 2022 1
Purpose Present updated information on the cost-benefit guidance project Facilitate public comment on the draft appendices to NUREG/BR-0058, Revision 5, Regulatory Analysis Guidelines of the U.S. Nuclear Regulatory Commission 2
Logistics and Ground Rules INFORMATION MEETING WITH A QUESTION AND ANSWER SESSION PLEASE IDENTIFY YOURSELF AND THE ORGANIZATION YOU REPRESENT (IF ANY) BEFORE SPEAKING 3
Questions are Encouraged 4
Agenda
Background
Overview of Appendices K and L Question and answer Next steps How to provide comments 5
=
Background===
NUREG/BR-0058 appendices were developed for specific technical areas related to regulatory analysis so that each can be revised independently Portions of NUREG/BR-0058 and appendices are currently with the Commission for review and approval prior to issuance Final guidance document and five appendices (2020)
Four appendices (2022) 6
Overview of Appendices K and L 7
Appendix K:
Monetary Valuation of Nonfatal Cancer Risk for Use in Cost-Benefit Analysis 8
=
Background===
What has changed?
NUREG-1530, Revision 1, Reassessment of the NRCs Dollar per Person-Rem Conversion Factor Policy, used the Environmental Protection Agencys cancer mortality risk coefficient Staff reviewed the current state of practice for the valuation of morbidity and nonfatal health risks to fill in the gap in quantifying averted morbidity costs SECY-20-0074, Valuing Nonfatal Cancer Risks in Cost-Benefit Analysis, informed the Commission of the staffs plan to develop a quality-adjusted life-year (QALY) approach Appendix K contains a method to quantify morbidity effects using the QALY approach 9
Appendix K Presents a dollar per person-rem conversion factor for averted cancer morbidity The benefits of an averted nonfatal cancer case are monetized using QALYs Cancer risk coefficient is the nonfatal component of the Environmental Protection Agency's cancer incidence risk coefficient 10
Appendix K Adds the morbidity conversion factor to the conversion factor for mortality risks in NUREG-1530, Rev.1, to provide a total health detriment conversion factor Provides the value of averted health risks from radiation exposure when applied to population collective dose 11
Appendix L:
Replacement Energy Costs 12
=
Background===
Replacement energy cost estimates are used to evaluate regulatory actions that Require safety modifications that might necessitate temporary reactor outages Reduce the potential for extended outages resulting from a severe reactor accident NUREG-2242, Replacement Energy Cost Estimates for Nuclear Power Plants: 2020-2030 Current replacement energy cost estimates for both short-and long-term outages Updates information provided in previous evaluations contained in NUREG/CR-4012 and NUREG/CR-6080 Technical approach, assumptions, and data sources for replacement energy cost estimates in Appendix L 13
Appendix L Guidance for estimating replacement energy costs for regulatory actions that may result in nuclear reactor outages Application of estimates provided in NUREG-2242, for use in cost-benefit analysis 14
Approach and Methodology Replacement energy costs refer to changes in wholesale power prices that would result when a reactor unit is taken offline Replacement energy attributes Shutdown costs to install or implement mandated safety changes Present value of averted onsite costs due to changes in reactor accident frequencies Details methods and provides examples on how to quantify using the information in NUREG-2242 15
Questions and Answers 16
Next Steps Consider feedback from this public meeting and formal public comments submitted when developing the final appendices Submit final appendices to the Commission for review and approval 17
How to Provide Comments
Federal Rulemaking Web Site http://www.regulations.gov Docket ID NRC-2017-0091 Comments due by September 6, 2022
NRC Contacts Docket questions: Dawn Forder, 301-415-3407, Dawn.Forder@nrc.gov Technical questions: Pamela Noto, 301-415-6795, Pamela.Noto@nrc.gov 18
How Did We Do?
There are several ways you can provide your feedback on this meeting:
Scan QR code for NRC Public Meeting Feedback Form Go to the Public Meeting Schedule and click on the Meeting Feedback link.
19
References SECY-20-0008 available at ML19261A277 (package)
SECY-22-0028 available at ML21228A118 (package)
SECY-20-0074 available at ML20058C219 (package)
NUREG-1530, Revision 1 available at ML22053A025 NUREG-2242 available at ML2117A176 NUREG/CR-4012 available at ML20073J435 NUREG/CR-6080 available at ML20076F500 20